BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18383830)

  • 1. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
    Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
    Gormus U; Ergen A; Yilmaz H; Dalan B; Berkman S; Isbir T
    Anticancer Res; 2007; 27(2):991-4. PubMed ID: 17465232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
    Zhang W; Li C; Wang J; He C
    Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
    Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
    Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
    Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
    J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
    Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BB genotype of heat-shock protein (HSP) 70-2 gene is associated with gastric pre-malignant condition in H. pylori-infected older patients.
    Tahara T; Shibata T; Arisawa T; Nakamura M; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Yamashita H; Nakano H; Hirata I
    Anticancer Res; 2009 Aug; 29(8):3453-8. PubMed ID: 19661373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians.
    Kupcinskas J; Wex T; Bornschein J; Selgrad M; Leja M; Juozaityte E; Kiudelis G; Jonaitis L; Malfertheiner P
    BMC Med Genet; 2011 Aug; 12():112. PubMed ID: 21864388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between an insertion-deletion polymorphism in the pepsinogen C gene and gastric cancer as well as its precursors].
    Sun LP; Guo XL; Zhang Y; Chen W; Bai XL; Liu J; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3059-63. PubMed ID: 17288837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population.
    Leung WK; Chan MC; To KF; Man EP; Ng EK; Chu ES; Lau JY; Lin SR; Sung JJ
    Am J Gastroenterol; 2006 Apr; 101(4):714-20. PubMed ID: 16635219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
    Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
    Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the myeloperoxidase polymorphism with the risk of gastric cancer.
    Hsu PI; Jwo JJ; Yang CL; Hsu PN; Yang HB; Lai KH; Chen IS; Chuah SK; Wu DC; Chen A
    Anticancer Res; 2008; 28(2B):1317-23. PubMed ID: 18505072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.